(Q38002125)

26 August 2017

title

Epileptic encephalitis: the role of the innate and adaptive immune system (English)

1 reference

26 August 2017

main subject

adaptive immune system

1 reference

1 reference

2

Annamaria Vezzani

1 reference

26 August 2017

Jan Bauer

1

1 reference

26 August 2017

Christian G Bien

series ordinal

3

1 reference

26 August 2017

publication date

1 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

22

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

412-421

1 reference

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Astrocytes are a specific immunological target in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

The natural history of Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

An open study of tacrolimus therapy in Rasmussen encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Potassium channel antibodies in two patients with reversible limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Central activation of thermogenesis and fever by interleukin-1 beta and interleukin-1 alpha involves different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Antibodies and neuronal autoimmune disorders of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Dementia and adult-onset unprovoked seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Histopathology of VGKC antibody-associated limbic encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Rasmussen encephalitis with active inflammation and delayed seizures onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Stiff man syndrome and related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Convulsants induce interleukin-1 beta messenger RNA in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Stroke in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Anterior callosotomy in the treatment of medically intractable epilepsies: a study of 43 patients with a mean follow-up of 39 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Voltage‐gated potassium channel antibodies in limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Focal seizures due to chronic localized encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

The IL-1beta system in epilepsy-associated malformations of cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Regulation of innate immune responses in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Epilepsia partialis continua. A review of 32 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: A light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Glia-neuron intercommunications and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

The role of inflammation in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Autoantibodies associated with diseases of the CNS: new developments and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Cytokines and neuronal ion channels in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

The Pathology of Rasmussen Syndrome: Stages of Cortical Involvement and Neuropathological Studies in 45 Hemispherectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00580.X

10.1111/J.1750-3639.2012.00580.X

21 January 2018

Identifiers

DOI

1 reference

release_oobatojkondnbhrj7k7tilyzse

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oobatojkondnbhrj7k7tilyzse

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference